| ID Source | ID |
|---|---|
| PubMed CID | 24555 |
| CHEBI ID | 30495 |
| MeSH ID | M0183737 |
| Synonym |
|---|
| tetrafluoridosulfur |
| CHEBI:30495 |
| 7783-60-0 |
| [sf4] |
| sulfur(4+) fluoride |
| sulfur tetrafluoride |
| sulfur(iv) fluoride |
| sulfur fluoride (sf4), (t-4)- |
| SF4 , |
| tetrafluorosulfurane |
| sulphur tetrafluoride |
| einecs 232-013-4 |
| sulfur fluoride, (t-4)- |
| sulfur fluoride (sf4), (beta-4)- |
| un2418 |
| hsdb 6339 |
| tetrafluoro-$l^{4}-sulfane |
| tetrakis(fluoranyl)-$l^{4}-sulfane |
| A839224 |
| unii-f4p8j39gof |
| sulfur tetrafluoride [un2418] [poison gas] |
| f4p8j39gof , |
| sulfur tetrafluoride [mi] |
| sulfur fluoride (sf4) |
| un-2418 |
| (t-4)-sulfur flouride (sf4) |
| un 2418 |
| mfcd00040327 |
| DTXSID40893074 |
| Q414732 |
| FT-0704820 |
| tetrafluoro-lambda4-sulfane |
| tetrafluoro--sulfane |
| Class | Description |
|---|---|
| sulfur coordination entity | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (62.69) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||